Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:13260  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 

    Article Cited by others

ORIGINAL ARTICLE

CSE-1034 versus ceftriaxone: Efficacy and safety analysis from a randomized, open-labeled phase III study in complicated urinary tract infections

Chaudhary Manu, Ayub Shiekh Gazalla, Mir Mohd Amin, Members of Study Group*

Year : 2018| Volume: 10| Issue : 4 | Page no: 188-195

   This article has been cited by
 
1 Antibacterial data synthesis challenges: a systematic review of treatments for complicated gram-negative urinary tract infections
Ryan Dillon, Jennifer Uyei, Rajpal Singh, Eilish McCann
Journal of Comparative Effectiveness Research. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 CSE (Ceftriaxone+ Sulbactam+ Disodium Edta): A Possible Solution to the Global Antimicrobial Resistance Pandemic
Shalini Upadhyay, Anita Chakravarti, Tanisha Bharara, Sushmita Yadav
Journal of Pure and Applied Microbiology. 2020; 14(3): 2039
[Pubmed]  [Google Scholar] [DOI]
3 A Small-Molecule Modulator of Metal Homeostasis in Gram-Positive Pathogens
Lillian J. Juttukonda, William N. Beavers, Daisy Unsihuay, Kwangho Kim, Gleb Pishchany, Kyle J. Horning, Andy Weiss, Hassan Al-Tameemi, Jeffrey M. Boyd, Gary A. Sulikowski, Aaron B. Bowman, Eric P. Skaar, Paul Dunman
mBio. 2020; 11(5)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article
Sitemap | What's New | Feedback | Copyright and Disclaimer | Privacy Notice | Contact Us
2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008